COTA is an AI and biotechnology startup in the healthcare and life sciences industries, based in the United States. Established in 2011, the company's mission is to bring clarity to cancer care, as reflected in its slogan "Together, we can bring clarity to cancer care." COTA was founded by doctors, engineers, and data scientists with the aim of creating clarity from fragmented and often-inaccessible real-world data.
Using its proprietary technology, advanced analytics, and deep expertise, COTA organizes complex data to provide a comprehensive picture of cancer, advancing care and research with the data. The company's vision is to ensure that everyone affected by cancer has a clear path to care and to make this vision a reality.
The most recent investment in COTA was a Series E round, with Deerfield as the investor, which took place on 25 October 2022.